Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 46

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 46
---
 our company performance, thus enabling the compensation & people committee to, among other things, (a) eliminate the potential incentive for management to conduct activities that are in the company’s annual goals, but which may not, due to new data or other inputs, ultimately prove to be in the best interest of stockholders, and (b) reward management for making decisions that are in the long-term best interest of our product development programs, even when those decisions result in the failure to meet short-term objectives. |

32

Director Compensation Our board of directors has adopted a non-employeedirector compensation policy that is designed to provide a total compensation package that enables us to attract and retain, on a long-term basis, high caliber non-employeedirectors. The cash and equity compensation for non-employeedirectors under the policy, effective January 1, 2025, is set forth in the table below. The changes in our non-employee directorcompensation policy effective January 1, 2025 (as compared to the policy in effect during the year ended December 31, 2024) were to (i) increase the annual cash compensation for our board chair from $30,000 to $35,000, (ii) increase the annual cash compensation for our lead independent director from $25,000 to $30,000, (iii) increase the annual cash compensation for our compensation & people committee members to $17,500 (for the chair) and $8,750 (for the other members), from $15,000 and $7,500, respectively, and (iv) increase the value of annual equity awards granted to non-employee directorsfrom $360,000 to $400,000, in each case to more closely align with market medians.

|                                                |     | Annual Cash Compensation |            |     | Number of Options/RSUs Granted                                                                                                                                                                                                                                                         |
| Board of Directors:                            |     |                          |            |     |                                                                                                                                                                                                                                                                                        |
| Board Member                                   |     |                          |    $50,000 |     | $630,000 in equity awards upon initial election (split approximately 75% in stock options and 25% in RSUs, based on value); $400,000 in equity awards immediately following each annual meeting thereafter (split approximately 75% in stock options and 25% in RSUs, based on value)* |
| Chair                                          |     |                          | Additional 
    $35,000 |     | —                                                                                                                                                                                                                                                                                      |
| Lead